293 related articles for article (PubMed ID: 8995588)
1. Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers.
Navenot JM; Villanova M; Lucas-Héron B; Malandrini A; Blanchard D; Louboutin JP
Muscle Nerve; 1997 Jan; 20(1):92-6. PubMed ID: 8995588
[TBL] [Abstract][Full Text] [Related]
2. Isolation and functional assay of the membrane complement inhibitors CD55 (DAF) and CD59 (MIRL).
Parker CJ
Curr Protoc Immunol; 2001 May; Chapter 13():13.5.1-13.5.18. PubMed ID: 18432718
[TBL] [Abstract][Full Text] [Related]
3. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M
Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979
[TBL] [Abstract][Full Text] [Related]
5. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.
Farkas I; Baranyi L; Ishikawa Y; Okada N; Bohata C; Budai D; Fukuda A; Imai M; Okada H
J Physiol; 2002 Mar; 539(Pt 2):537-45. PubMed ID: 11882685
[TBL] [Abstract][Full Text] [Related]
6. The terminal complement complex is generated in chronic leg ulcers in the absence of protectin (CD59).
Balslev E; Thomsen HK; Danielsen L; Sheller J; Garred P
APMIS; 1999 Nov; 107(11):997-1004. PubMed ID: 10598871
[TBL] [Abstract][Full Text] [Related]
7. Critical protection from renal ischemia reperfusion injury by CD55 and CD59.
Yamada K; Miwa T; Liu J; Nangaku M; Song WC
J Immunol; 2004 Mar; 172(6):3869-75. PubMed ID: 15004194
[TBL] [Abstract][Full Text] [Related]
8. Trimeresurus flavoviridis (habu snake) venom induces human erythrocyte lysis through enzymatic lipolysis, complement activation and decreased membrane expression of CD55 and CD59.
Yamamoto C; Tsuru D; Oda-Ueda N; Ohno M; Hattori S; Kim ST
Pharmacol Toxicol; 2001 Oct; 89(4):188-94. PubMed ID: 11881969
[TBL] [Abstract][Full Text] [Related]
9. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
Miwa T; Zhou L; Hilliard B; Molina H; Song WC
Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
[TBL] [Abstract][Full Text] [Related]
10. Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization.
Li Y; Parks GD
Viruses; 2018 Apr; 10(5):. PubMed ID: 29693588
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of CD46, CD55, and CD59 on complement activation after immunotherapeutic treatment of cervical carcinoma cells with monoclonal antibodies or bispecific monoclonal antibodies.
Gelderman KA; Blok VT; Fleuren GJ; Gorter A
Lab Invest; 2002 Apr; 82(4):483-93. PubMed ID: 11950905
[TBL] [Abstract][Full Text] [Related]
12. Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacrimal gland.
Bardenstein DS; Dietz Y; Lass JH; Medof ME
Curr Eye Res; 1994 Dec; 13(12):851-5. PubMed ID: 7536649
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for membrane attack complex inhibition by CD59.
Couves EC; Gardner S; Voisin TB; Bickel JK; Stansfeld PJ; Tate EW; Bubeck D
Nat Commun; 2023 Feb; 14(1):890. PubMed ID: 36797260
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
[TBL] [Abstract][Full Text] [Related]
15. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
16. Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by autologous complement activation.
Mizuno T; Mizuno M; Morgan BP; Noda Y; Yamada K; Okada N; Yuzawa Y; Matsuo S; Ito Y
Nephrol Dial Transplant; 2011 Jun; 26(6):1821-30. PubMed ID: 21098015
[TBL] [Abstract][Full Text] [Related]
17. Quantification of the CD55 and CD59, membrane inhibitors of complement on HIV-1 particles as a function of complement-mediated virolysis.
Nakamura M; Okada H; Sasaki H; Yoshida K; Kamada M; Okada N; Terada M; Ohno T
Microbiol Immunol; 1996; 40(8):561-7. PubMed ID: 8887350
[TBL] [Abstract][Full Text] [Related]
18. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244
[TBL] [Abstract][Full Text] [Related]
19. The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues.
Thorsteinsson L; O'Dowd GM; Harrington PM; Johnson PM
APMIS; 1998 Sep; 106(9):869-78. PubMed ID: 9808413
[TBL] [Abstract][Full Text] [Related]
20. Test for ability of decay-accelerating factor (DAF, CD55) and CD59 to alleviate complement-mediated damage of xeno-erythrocytes.
Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Kitamura H; Seya T
Scand J Immunol; 1993 Jul; 38(1):37-44. PubMed ID: 7687071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
